Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Avanos Medical Sees 2025 Net Sales To Be Between $665M-$685M Vs. $713.13M Estimate, And Adjusted Diluted Earnings Per Share Are Expected To Be Between $1.05-$1.25 Vs. $1.67 Estimate

Author: Benzinga Newsdesk | February 26, 2025 07:07am

Posted In: AVNS